Synergistic effect of estradiol and fluoxetine in young adult and middle-aged female rats in two models of experimental depression.
The antidepressant effect of estrogens combined with antidepressants is controversial: some preclinical data showed that estrogens facilitate the effect of antidepressants in the forced swimming test (FST) in young adult rats, while others failed to find such effect in middle-aged rats in the chronic mild stress (CMS) model. In clinics similar differences were reported and may be due to the compounds, the depression model or type of depression, the experimental design, and the age of the subjects or the women's menopause stage. The objective of this study was to analyze the antidepressant-like effect of the combination of 17β-estradiol (E(2)) and fluoxetine (FLX) in young adults (2-4 months) and middle-aged (12-14 months) ovariectomized (OVX) rats in two experimental models: FST and CMS. E(2) (5 and 10 μg/rat) and FLX (2.5 and 10 mg/kg) per se dose-dependently reduced immobility in both age groups and, in young adults both compounds increased swimming, whereas in middle-aged rats they increased swimming and climbing. Analysis of the antidepressant-like effect of the combination of suboptimal doses of FLX (1.25 mg/kg) and E(2) (2.5 μg/rat) showed a decrease in immobility and an increase in swimming in both age groups. In the CMS, chronic E(2) (2.5 μg/rat) with FLX (1.25 mg/kg) augmented relative sucrose intake, but middle-aged rats responded 2 weeks earlier than young adults. These results show that the antidepressant-like effect of the combination of E(2) and FLX in young adult and middle-aged female rats is evidenced in the two animal models of depression: FST and CMS.
Departament of Pharmacobiology, Center for Research and Advanced Studies (CINVESTAV), Mexico.
Soledad
S
Récamier-Carballo
Erika
E
Estrada-Camarena
Rebeca
R
Reyes
Alonso
A
Fernández-Guasti
D000375:Aging; D000704:Analysis of Variance; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy*; D004195:Disease Models, Animal; D004357:Drug Synergism; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D005518:Food Preferences / Q000187:drug effects; D046353:Immobility Response, Tonic / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D010052:Ovariectomy; D051381:Rats; D013315:Stress, Psychological / Q000188:drug therapy; D013395:Sucrose; D013550:Swimming / Q000523:psychology
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine; D004958:Estradiol; D013395:Sucrose